MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jmoldx.2026.01.002

Медицинская библиотека · The Journal of molecular diagnostics : JMD · 2026

Technical Validation and Prospective Clinical Utility of Optical Genome Mapping in Acute Leukemia Workup: Insights from 200 Cases following Deployment as a First-Line Diagnostic Test in a Tertiary Care Center.

Parlow Julia N C, Hamadeh Zeid, Salcedo-Porras Nicolas, AlBulushi Fatma, McGinnis Eric, Spence Tara

СтатьяПеревод пока не подготовлен

Аннотация

In November 2023, our Canadian tertiary care facility implemented optical genome mapping (OGM) as a first-line diagnostic test for adults with newly diagnosed acute leukemias. Here, the analytical performance and clinical utility of OGM alongside karyotype, fluorescence in situ hybridization (FISH), and next-generation sequencing are reported. During test validation, OGM demonstrated robust analytical performance, reproducibility, and limits of detection, revealing 100% specificity, 96.1% sensitivity, and 98.0% accuracy. After implementation, clinical reports from the entire cytogenetic and molecular genetic workflow were prospectively compiled from the first 200 cases to evaluate concordance with parallel karyotype/FISH and added yield of OGM. A total of 640 reportable variants were detected by OGM and stratified on the basis of clinical significance, classified as tier 1A (25%), tier 1B (3%), tier 2 (2%), or tier 3A (70%). Of these, 64 variants were missed by karyotype and FISH, 3 KMT2A partial tandem duplications were missed by next-generation sequencing, and 9 cases with failed karyotype were rescued by OGM: overall impacting 35 cases (18%) by altering diagnostic classification (n = 12) and/or risk stratification (n = 31). Despite comprehensive pre-existing diagnostic workflows, implementation of OGM has revealed diagnostically and prognostically significant alterations in cases otherwise cryptic or failed by karyotype, demonstrating strong clinical utility and supporting its use as a first-tier diagnostic test for hematolymphoid malignancies.

Для цитирования: Parlow Julia N C, Hamadeh Zeid, Salcedo-Porras Nicolas, AlBulushi Fatma, McGinnis Eric, Spence Tara. Technical Validation and Prospective Clinical Utility of Optical Genome Mapping in Acute Leukemia Workup: Insights from 200 Cases following Deployment as a First-Line Diagnostic Test in a Tertiary Care Center.. The Journal of molecular diagnostics : JMD. 2026. DOI: 10.1016/j.jmoldx.2026.01.002.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.